Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Oxybutynin hydrochloride 2.5mg; ;
Ethos Consulting Group
Oxybutynin hydrochloride 2.5 mg
2.5 mg
Tablet
Active: Oxybutynin hydrochloride 2.5mg Excipient: Crospovidone Lactose monohydrate Magnesium stearate Microcrystalline cellulose
Blister pack, PVC/PVdC/Al, 100 tablets
Prescription
Prescription
Resonance Laboratories Pvt Ltd
Oxybutynin ADE is primarily indicated for the management of urgency and incontinence that characterise neurogenic bladder disorders and idiopathic detrusor instability.
Package - Contents - Shelf Life: Blister pack, PVC/PVdC/Al - 100 tablets - 24 months from date of manufacture stored at or below 25°C
2010-11-02
1 OXYBUTYNIN ADE 21112011 New Zealand Consumer Medicine Information OXYBUTYNIN ADE _OXYBUTYNIN HYDROCHLORIDE _ 2.5 mg and 5 mg Tablets WHAT IS IN THIS LEAFLET Please read this leaflet carefully before you start using Oxybutynin ADE. This leaflet answers some common questions about Oxybutynin ADE. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Oxybutynin ADE against the benefits he/she expects it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT OXYBUTYNIN ADE IS USED FOR Oxybutynin ADE is used to decrease the urgency and the frequency of urination. It belongs to a group of medicines called anticholinergics. Oxybutynin ADE works by relaxing the smooth muscle of the bladder and thereby decreases muscle spasms. These spasms are the cause of the feeling of having to urinate frequently, which in turn can lead to involuntary loss of urine. Furthermore, when the bladder muscle is relaxed, the bladder can hold more urine and the frequent urge to urinate is reduced. Your doctor may have prescribed it for another reason. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Oxybutynin ADE is available only with a doctor's prescription. There is no evidence that Oxybutynin ADE is addictive. 2 OXYBUTYNIN ADE 21112011 BEFORE YOU TAKE OXYBUTYNIN ADE _ _ _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE OXYBUTYNIN ADE IF YOU HAVE: • narrow angle glaucoma or shallow anterior cham Read the complete document
1 OXYBUTYNIN ADE 21112011 NEW ZEALAND DATA SHEET OXYBUTYNIN ADE OXYBUTYNIN HYDROCHLORIDE TABLETS 2.5 MG AND 5 MG PRESENTATION Oxybutynin ADE 2.5 tablets are white, round, flat, bevel-edged tablets, embossed with ‘2.5’ on one side. Each tablet contains oxybutynin hydrochloride 2.5 mg. Oxybutynin ADE 5 tablets are white, round, flat, bevel-edged tablets, embossed with ‘5’ on one side, and embossing on the reverse. Each tablet contains oxybutynin hydrochloride 5 mg. INDICATIONS Oxybutynin ADE is primarily indicated for the management of urgency and incontinence that characterise neurogenic bladder disorders and idiopathic detrusor instability. DOSAGE AND ADMINISTRATION Treatment should be initiated at a low dose and the dose should be titrated upwards based on clinical response and tolerance. CHILDREN _Children over 5 years:_ The usual maintenance dose is 5 mg taken twice daily. The maximum recommended dose is 5 mg taken three times daily. Oxybutynin ADE is not recommended for children under 5 years. ADULTS The usual maintenance dose is 5 mg taken two to three times daily. The maximum recommended dose is 5 mg taken four times daily. ELDERLY PATIENTS In the frail and elderly patient it is advisable to initiate treatment at a low dose and, if necessary, to increase the dose carefully according to tolerance and response. Initial doses for geriatric patients of 2.5 mg twice daily have been reported in the literature. 2 OXYBUTYNIN ADE 21112011 CONTRAINDICATIONS • Patients with unstable cardiovascular status in acute haemorrhage • Hypersensitivity to oxybutynin hydrochloride or any of the excipients of Oxybutynin ADE • Intestinal atony of the elderly or debilitated patient • Megacolon and toxic mega Read the complete document